Literature DB >> 11738045

Specificity in Trk receptor:neurotrophin interactions: the crystal structure of TrkB-d5 in complex with neurotrophin-4/5.

M J Banfield1, R L Naylor, A G Robertson, S J Allen, D Dawbarn, R L Brady.   

Abstract

BACKGROUND: The binding of neurotrophin ligands to their respective Trk cellular receptors initiates intracellular signals essential for the growth and survival of neurons. The site of neurotrophin binding has been located to the fifth extracellular domain of the Trk receptor, with this region regulating both the affinity and specificity of Trk receptor:neurotrophin interaction. Neurotrophin function has been implicated in a number of neurological disorders, including Alzheimer's disease and Parkinson's disease.
RESULTS: We have determined the 2.7 A crystal structure of neurotrophin-4/5 bound to the neurotrophin binding domain of its high-affinity receptor TrkB (TrkB-d5). As previously seen in the interaction of nerve growth factor with TrkA, neurotrophin-4/5 forms a crosslink between two spatially distant receptor molecules. The contacts formed in the TrkB-d5:neurotrophin-4/5 complex can be divided into a conserved area similar to a region observed in the TrkA-d5:NGF complex and a second site-unique in each ligand-receptor pair-formed primarily by the ordering of the neurotrophin N terminus.
CONCLUSIONS: Together, the structures of the TrkB-d5:NT-4/5 and TrkA-d5:NGF complexes confirm a consistent pattern of recognition in Trk receptor:neurotrophin complex formation. In both cases, the N terminus of the neurotrophin becomes ordered only on complex formation. This ordering appears to be directed largely by the receptor surface, with the resulting complementary surfaces providing the main determinant of receptor specificity. These features provide an explanation both for the limited crossreactivity observed between the range of neurotrophins and Trk receptors and for the high-affinity binding associated with respective ligand-receptor pairs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738045     DOI: 10.1016/s0969-2126(01)00681-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  37 in total

1.  Role of the conformational versatility of the neurotrophin N-terminal regions in their recognition by Trk receptors.

Authors:  Francesca Stanzione; Luciana Esposito; Antonella Paladino; Carlo Pedone; Giancarlo Morelli; Luigi Vitagliano
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor.

Authors:  M Cazorla; J M Arrang; J Prémont
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A.

Authors:  Marco Berrera; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

4.  Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia.

Authors:  Brunella Cristofaro; Oliver A Stone; Andrea Caporali; David Dawbarn; Nicholas Ieronimakis; Morayma Reyes; Paolo Madeddu; David O Bates; Costanza Emanueli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-01       Impact factor: 8.311

5.  The effect of P75 on Trk receptors in neuroblastomas.

Authors:  Ruth Ho; Jane E Minturn; Anisha M Simpson; Radhika Iyer; Jennifer E Light; Audrey E Evans; Garrett M Brodeur
Journal:  Cancer Lett       Date:  2011-03-17       Impact factor: 8.679

6.  ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin.

Authors:  Henry K Teng; Kenneth K Teng; Ramee Lee; Saundrene Wright; Seema Tevar; Ramiro D Almeida; Pouneh Kermani; Risa Torkin; Zhe-Yu Chen; Francis S Lee; Rosemary T Kraemer; Anders Nykjaer; Barbara L Hempstead
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

7.  Identification of a novel mutation in the NTF4 gene that causes primary open-angle glaucoma in a Chinese population.

Authors:  Eranga N Vithana; Monisha E Nongpiur; Divya Venkataraman; Stephanie H Chan; Jagadeesh Mavinahalli; Tin Aung
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

8.  Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma.

Authors:  Francesca Pasutto; Tomoya Matsumoto; Christian Y Mardin; Heinrich Sticht; Johann H Brandstätter; Karin Michels-Rautenstrauss; Nicole Weisschuh; Eugen Gramer; Wishal D Ramdas; Leonieke M E van Koolwijk; Caroline C W Klaver; Johannes R Vingerling; Bernhard H F Weber; Friedrich E Kruse; Bernd Rautenstrauss; Yves-Alain Barde; André Reis
Journal:  Am J Hum Genet       Date:  2009-09-17       Impact factor: 11.025

9.  Directed evolution of brain-derived neurotrophic factor for improved folding and expression in Saccharomyces cerevisiae.

Authors:  Michael L Burns; Thomas M Malott; Kevin J Metcalf; Benjamin J Hackel; Jonah R Chan; Eric V Shusta
Journal:  Appl Environ Microbiol       Date:  2014-07-11       Impact factor: 4.792

10.  Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury.

Authors:  Van B Lu; James E Biggs; Martin J Stebbing; Sridhar Balasubramanyan; Kathryn G Todd; Aaron Y Lai; William F Colmers; David Dawbarn; Klaus Ballanyi; Peter A Smith
Journal:  J Physiol       Date:  2009-01-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.